Abstract
Although the prevalence rates of celiac disease tend to be very similar in different Western populations, mortality rates for this disease vary widely. In this Review we focus on the papers that have addressed this issue so far. We evaluated mortality rates in different forms of celiac disease, such as symptomatic celiac disease, unrecognized celiac disease, dermatitis herpetiformis and refractory celiac disease. We also evaluated the role of possible protective factors, such as adherence to a gluten-free diet, early diagnosis and severity of clinical presentation. Finally, we noticed that the mortality rate for celiac disease seems to be higher in Southern than in Northern Europe and seems to correlate with 'national' gluten consumption. To explain these differences, we propose a hypothesis that links mortality rates to the amount of gluten consumed not only after but also before the diagnosis of celiac disease.
Key Points
-
Mortality rates in patients with celiac disease are increased compared with the general population
-
Reported mortality rates vary between studies
-
Increased mortality in patients with celiac disease is mainly due to malignancies
-
Overall, mortality rates decrease over time from diagnosis
-
Early diagnosis and a strict gluten-free diet are protective
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nielsen, O. H. et al. Non-tropical sprue. Malignant diseases and mortality rate. Scand. J. Gastroenterol. 20, 13–18 (1985).
Logan, R. F., Rifkind, E. A., Turner, I. D. & Ferguson, A. Mortality in celiac disease. Gastroenterology 97, 265–271 (1989).
Swerdlow, A. J., Whittaker, S., Carpenter, L. M. & English, J. S. Mortality and cancer incidence in patients with dermatitis herpetiformis: a cohort study. Br. J. Dermatol. 129, 140–144 (1993).
Collin, P. et al. Coeliac disease-associated disorders and survival. Gut 35, 1215–1218 (1994).
Collin, P., Pukkala, E. & Reunala, T. Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease. Gut 38, 528–530 (1996).
Johnston, S. D., Watson, R. G., McMillan, S. A., Sloan, J. & Love, A. H. Coeliac disease detected by screening is not silent—simply unrecognized. QJM 91, 853–860 (1998).
Cottone, M. et al. Mortality and causes of death in celiac disease in a Mediterranean area. Dig. Dis. Sci. 44, 2538–2541 (1999).
Corrao, G. et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 358, 356–361 (2001).
Seraphin, P. & Mobarhan, S. Mortality in patients with celiac disease. Nutr. Rev. 60, 116–118 (2002).
Peters, U., Askling, J., Gridley, G., Ekbom, A. & Linet, M. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch. Intern. Med. 163, 1566–1572 (2003).
West, J., Logan, R. F., Smith, C. J., Hubbard, R. B. & Card, T. R. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ 329, 716–719 (2004).
Metzger, M. H. et al. Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA/MONICA Augsburg cohort study 1989–1998. Eur. J. Epidemiol. 21, 359–365 (2006).
Viljamaa, M. et al. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig. Liver Dis. 38, 374–380 (2006).
Anderson, L. A. et al. Malignancy and mortality in a population-based cohort of patients with coeliac disease or “gluten sensitivity”. World J. Gastroenterol. 13, 146–151 (2007).
Solaymani-Dodaran, M., West, J. & Logan, R. F. Long-term mortality in people with celiac disease diagnosed in childhood compared with adulthood: a population-based cohort study. Am. J. Gastroenterol. 102, 864–870 (2007).
Al-Toma, A., Verbeek, W. H., Hadithi, M., von Blomberg, B. M. & Mulder, C. J. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut 56, 1373–1378 (2007).
Lewis, N. R., Logan, R. F., Hubbard, R. B. & West, J. No increase in risk of fracture, malignancy or mortality in dermatitis herpetiformis: a cohort study. Aliment. Pharmacol. Ther. 27, 1140–1147 (2008).
Lohi, S. et al. Prognosis of unrecognized coeliac disease as regards mortality: a population-based cohort study. Ann. Med. 23, 1–8 (2009).
Rubio-Tapia, A. et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 137, 88–93 (2009).
Malamut, G. et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 136, 81–90 (2009).
Rubio-Tapia, A. et al. Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology 136, 99–107 (2009).
Ludvigsson, J. F., Montgomery, S. M., Ekbom, A., Brandt, L. & Granath, F. Small-intestinal histopathology and mortality risk in celiac disease. JAMA 302, 1171–1178 (2009).
Holmes, G. K., Prior, P., Lane, M. R., Pope, D. & Allan, R. N. Malignancy in coeliac disease-effect of a gluten free diet. Gut 30, 333–338 (1989).
Leonard, J. N. et al. Increased incidence of malignancy in dermatitis herpetiformis. BMJ 286, 16–18 (1983).
Marsh, M. N. & Crowe, P. T. Morphology of the mucosal lesion in gluten sensitivity. Bailliere Clin. Gastroenterol. 9, 273–293 (1995).
Macdonald, W. C., Brandborg, L. L., Flick, A. L., Trier, J. S. & Rubin, C. E. Studies of celiac sprue. IV. The response of the whole length of the small bowel to a gluten-free diet. Gastroenterology 47, 573–589 (1964).
Fry, L. Dermatits herpetiformis. Bailliere Clin. Gastroenterol. 9, 371–393 (1995).
Biagi, F. & Corazza, G. R. Defining “gluten refractory enteropathy”. Eur. J. Gastroenterol. Hepat. 13, 561–565 (2001).
Catassi, C. et al. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am. J. Clin. Nutr. 85, 160–166 (2007).
Dubé, C. et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 128 (4 Suppl. 1), S57–S67 (2005).
UN A. F. P. A. Pasta consumption in the EU (1990-2008) [online], (2009).
Chinnici, G. Analisi del consumo di pane in Sicilia (Italian) Il Grano Duro [online], (2009).
Pasta It Pasta Production and Consumption (Italian) [online], (2009).
Collin, P. Should adults be screened for celiac disease? What are the benefits and harms of screening? Gastroenterology 128 (Suppl. 1), S104–S108 (2005).
Acknowledgements
We are grateful to S. West for reading and correcting the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Biagi, F., Corazza, G. Mortality in celiac disease. Nat Rev Gastroenterol Hepatol 7, 158–162 (2010). https://doi.org/10.1038/nrgastro.2010.2
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2010.2
This article is cited by
-
Long-Term Adherence to a Gluten-Free Diet and Quality of Life of Celiac Patients After Transition to an Adult Referral Center
Digestive Diseases and Sciences (2022)
-
Safety of occasional ingestion of gluten in patients with celiac disease: a real-life study
BMC Medicine (2020)
-
Coeliac disease
Nature Reviews Disease Primers (2019)
-
A low-gluten diet induces changes in the intestinal microbiome of healthy Danish adults
Nature Communications (2018)
-
Improving the Stability and Activity of Oral Therapeutic Enzymes—Recent Advances and Perspectives
Pharmaceutical Research (2014)